Azacitidine and Erythropoietin Versus Azacitidine Alone for Patients With Low-Risk Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases
- Status
- COMPLETED
- Phase
- NA
Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases
- Status
- TERMINATED
- Phase
- PHASE1
Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
MGCD0103 in Elderly Patients With Previously Untreated AML/High Risk MDS or Adults With Relapsed/Refractory Disease
- Status
- TERMINATED
- Phase
- PHASE2
Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Vaccine Therapy in Treating Patients With Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)
- Status
- COMPLETED
- Phase
- PHASE4
Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Cyclophosphamide Plus T-Cell Transplantation for Patients With Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers.
- Status
- TERMINATED
- Phase
- PHASE2
Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
An Ascending Dose Study of KW-2449 in Acute Leukemias, Myelodysplastic Syndromes, and Chronic Myelogenous Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clofarabine and Ara-C for the Treatment of Relapsed AML and Untreated MDS
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation
- Status
- UNKNOWN
- Phase
- PHASE2
Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE3
A Phase I Study of MGCD0103 Given Twice Weekly in Patients With Leukemia or Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Study of MGCD0103 Given Three-Times Weekly In Patients With Leukemia Or Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE1
Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2